Encompass Health reports Q4 adjusted EPS 95c, consensus 82c

Reports Q4 revenue $1.25B, consensus $1.24B. “The fourth quarter was a very strong finish to 2023,” said President and CEO of Encompass Health Mark Tarr. “Strong discharge growth facilitated a fourth quarter increase of 9.6% in net operating revenue and Adjusted EBITDA. For the full year, net operating revenue increased 10.4% and Adjusted EBITDA grew 18.5%. Our value proposition and operating strategy continue to be validated and we remain highly optimistic about the long-term prospects of our business.”